Hong, B., Chapa, V., Saini, U., Modgil, P., Cohn, D. E., He, G., . . . Kaur, B. (2021). Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity. Clinical cancer research, 27(2), 542-553. https://doi.org/10.1158/1078-0432.CCR-20-2210
Chicago Style (17th ed.) CitationHong, Bangxing, et al. "Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity." Clinical Cancer Research 27, no. 2 (2021): 542-553. https://doi.org/10.1158/1078-0432.CCR-20-2210.
MLA (9th ed.) CitationHong, Bangxing, et al. "Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity." Clinical Cancer Research, vol. 27, no. 2, 2021, pp. 542-553, https://doi.org/10.1158/1078-0432.CCR-20-2210.